All News
The ENDD team is excited to participate in Research Roundtable at the 2026 STXBP1 Summit+ right here in Philly! Several ENDD researchers will share their work,
Adding to his list of honors*, Alex Felix has won the 2026 Alavi-Dabiri Post-doctoral Research Award from the Intellectual and Developmental Disabilities Research Center at CHOP!
The 2026 Million Dollar Bike Ride takes place Saturday, June 13th. Check the MDBR site for more information and to sign up.
Alex Felix has won CURE Epilepsy’s Taking Flight Award to advance his work on “Fine-tuning the 3’UTR as a novel therapeutic strategy for genetic Developmental and Epileptic Encephalopathies.”
Charlene Son Rigby, President and Co-founder of the STXBP1 Foundation, interviews ENDD’s Mike Boland about STXBP1 therapeutic development updates from the annual meeting of the American Society for Gene and Cell Therapy.
From The Transmitter, by Lydia Denworth.
A handful of scientists are committed to advancing research on the autism-related genetic conditions their own children have.
In this piece in Current Problems in Pediatric and Adolescent Health Care, “Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders,”
Penn Medicine and Children’s Hospital of Philadelphia (CHOP) are establishing the Center for Epilepsy and Neurodevelopmental Disorders (ENDD) to accelerate collaborative research in genetic therapies for neurodevelopmental disorders.